Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

October 01, 1989; Volume 251,Issue 1
  • You have access
    The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
    S P Welch, A K Singha and W L Dewey
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 1-8;
  • You have access
    Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents.
    V Ganapathy, P Kulanthaivel, C Tiruppathi, V B Mahesh and F H Leibach
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 9-15;
  • You have access
    Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve.
    M A Oriowo, J A Bevan and R D Bevan
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 16-20;
  • You have access
    Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    H N Bhargava, A Gulati and P Ramarao
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 21-26;
  • You have access
    Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
    R E Solomon, M J Brody and G F Gebhart
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 27-38;
  • You have access
    Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    A Costard-Jäckle and M R Franz
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 39-46;
  • You have access
    CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
    A J Hutchison, R L Webb, H H Oei, G R Ghai, M B Zimmerman and M Williams
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 47-55;
  • You have access
    Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro.
    Z Z Pan and J T Williams
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 56-62;
  • You have access
    Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
    R K Hoover and M L Toews
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 63-70;
  • You have access
    The role of serotonin in the canine secretory response to cholera toxin in vivo.
    C A LaRosa, D Sherlock, K Kimura, W Pimpl, S R Money and B M Jaffe
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 71-76;
  • You have access
    Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
    J G Gerber, K S Bedell and A S Nies
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 77-81;
  • You have access
    Ammonium ions cause relaxation of isolated canine arteries.
    M Feletou, C T Harker, K Komori, J T Shepherd and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 82-89;
  • You have access
    The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
    L Mei, J Lai, H I Yamamura and W R Roeske
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 90-97;
  • You have access
    Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    G J Grover, J R McCullough, D E Henry, M L Conder and P G Sleph
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 98-104;
  • You have access
    CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    T G Heffner, D A Downs, L T Meltzer, J N Wiley and A E Williams
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 105-112;
  • You have access
    CI-943, a potential antipsychotic agent. II. Neurochemical effects.
    T A Pugsley, L L Coughenour, S L Myers, Y H Shih, G G Courtland, W Berghoff and S F Stewart
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 113-122;
  • You have access
    CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    L T Meltzer, C L Christoffersen, T G Heffner, A S Freeman and L A Chiodo
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 123-130;
  • You have access
    Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen.
    B K Madras, M A Fahey, J Bergman, D R Canfield and R D Spealman
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 131-141;
  • You have access
    Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.
    R D Spealman, B K Madras and J Bergman
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 142-149;
  • You have access
    Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
    J Bergman, B K Madras, S E Johnson and R D Spealman
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 150-155;
  • You have access
    Inhibition of rat brain glutamate receptors by philanthotoxin.
    D Ragsdale, D B Gant, N A Anis, A T Eldefrawi, M E Eldefrawi, K Konno and R Miledi
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 156-163;
  • You have access
    Chronic ethanol treatment selectively increases the binding of inverse agonists for benzodiazepine binding sites in cultured spinal cord neurons.
    M Mhatre and M K Ticku
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 164-168;
  • You have access
    1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
    J J Galligan, B G Campbell, M P Kavanaugh, E Weber and R A North
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 169-174;
  • You have access
    Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
    R J Lukas
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 175-182;
  • You have access
    Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
    S Paul, E K Jackson, D Robertson, R A Branch and I Biaggioni
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 183-187;
  • You have access
    Specific inhibition of rat renal Na+/phosphate cotransport by picolinamide.
    P I Campbell, H A al-Mahrouq, M I Abraham and S A Kempson
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 188-192;
  • You have access
    Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase.
    D Y Mitchell and D R Petersen
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 193-198;
  • You have access
    Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.
    A L Harris, M J Connell, E W Ferguson, A M Wallace, R J Gordon, E D Pagani and P J Silver
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 199-206;
  • You have access
    High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents.
    M Klein and J M Musacchio
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 207-215;
  • You have access
    Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord.
    C W Stevens and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 216-223;
  • You have access
    Castanospermine-glucosides are potent, selective, long-acting sucrase inhibitors.
    K M Robinson, B L Rhinehart, M E Begovic, C H King and P S Liu
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 224-229;
  • You have access
    Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
    D R Kapusta, S Y Jones and G F DiBona
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 230-237;
  • You have access
    Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
    H Y Meltzer, S Matsubara and J C Lee
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 238-246;
  • You have access
    Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
    J E Shook, T F Burks, J W Wasley and J A Norman
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 247-252;
  • You have access
    Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Y Satoh, J D Kohli and L I Goldberg
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 253-257;
  • You have access
    Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
    S Ofori, R E Heikkila and W J Nicklas
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 258-266;
  • You have access
    Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
    M F Piercey and F J Einspahr
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 267-271;
  • You have access
    Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
    W J Martin, D L Kachel, T Vilen and V Natarajan
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 272-278;
  • You have access
    Effects of adenosine A2 receptor agonists on nucleoside transport.
    J L Balwierczak, C M Krulan, Z C Wang, J Chen and A Y Jeng
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 279-287;
  • You have access
    Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
    B C Sallustio, Y J Purdie, D J Birkett and P J Meffin
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 288-294;
  • You have access
    Renal handling of aspirin in the rat.
    F Gaspari, N Perico, M Locatelli, D Corna, G Remuzzi and S Garattini
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 295-304;
  • You have access
    Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.
    P Kostka, S N Sipos, C Y Kwan, L P Niles and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 305-310;
  • You have access
    Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits.
    V Joly, F Dromer, J Barge, P Yeni, N Seta, G Molas and C Carbon
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 311-316;
  • You have access
    Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery.
    K Manabe, H Shirahase, H Usui, K Kurahashi and M Fujiwara
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 317-320;
  • You have access
    Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition.
    I A Bakker-Woudenberg, A F Lokerse and F H Roerdink
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 321-327;
  • You have access
    Disposition and dynamics of atrial natriuretic factor in conscious rabbits.
    S Marleau, H Ong, A De Léan and P du Souich
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 328-333;
  • You have access
    Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli.
    M J Millan
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 334-341;
  • You have access
    Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    M J Millan, A Członkowski, A Lipkowski and A Herz
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 342-350;
  • You have access
    Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078 into the blood-brain barrier.
    T Terasaki, K Hirai, H Sato, Y S Kang and A Tsuji
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 351-357;
  • You have access
    Pharmacokinetics of recombinant human tumor necrosis factor alpha in rhesus monkeys after intravenous administration.
    A Greischel and G Zahn
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 358-361;
  • You have access
    Nonlinear relationship between benzodiazepine receptor occupancy and glucose metabolic response in the conscious mouse brain in vivo.
    H Ishizuka, Y Sawada, K Ito, Y Sugiyama, H Suzuki, T Iga and M Hanano
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 362-367;
  • You have access
    Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and squaric acid in human lymphocytes.
    T Lialiaris, D Mourelatos, L Boutis, A Papageorgiou, M Christianopoulou, V Papageorgiou and J Dozi-Vassiliades
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 368-371;
  • You have access
    Developmental changes of the G proteins-muscarinic cholinergic receptor interactions in rat heart.
    K K McMahon
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 372-377;
  • You have access
    Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
    P W Kalivas, P Duffy and J Barrow
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 378-387;
  • You have access
    A dose-response analysis of intra-raphe tachykinin-induced hyperactivity.
    J M Paris and S A Lorens
    Journal of Pharmacology and Experimental Therapeutics October 1989, 251 (1) 388-393;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 251, Issue 1
1 Oct 1989
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics